Drug shortage
Fentanyl Citrate Troche/Lozenge · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · To Be Discontinued · updated Sep 24, 2024
Key facts
| Generic name | Fentanyl Citrate Troche/Lozenge |
|---|---|
| Proprietary name | Actiq |
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Actiq, Troche/Lozenge, 600 ug (NDC 0093-7867-65) |
| Dosage form | Troche/Lozenge |
| Strength | 600 ug |
| Status | To Be Discontinued |
| Therapeutic category | Analgesia/Addiction |
| Package NDCs | 0093-7867-65 |
| First posted | Sep 24, 2024 |
| Last updated | Sep 24, 2024 |
| Discontinued | Sep 24, 2024 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: